GlycoScoreDx
United Kingdom
activeseed
seed
Stage
1
Investors
About
GlycoScoreDx focuses on prostate cancer diagnosis through its blood test. The GlycoScore Prostate Cancer Test utilizes a combination of glycan biomarkers to detect aggressive prostate cancer and differentiate it from benign conditions, thereby reducing the need for biopsies.
Explore GlycoScoreDx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.